News AI predicts heart attack risk factors from retinal scans Artificial Intelligence can be used to predict heart attack risk using retinal images, according to new research backed by Google.
Views & Analysis Digital health round-up: Could Nokia kill off digital health... Richard Staines gives a round-up of the latest developments in digital health over the last week.
News FDA makes history, approving Spark's eye gene therapy Christmas has come a few days early for Spark Therapeutics after the FDA approved its ground-breaking gene therapy for a rare eye disease.
Partner Content Partner Content Europe’s Leading Ophthalmic Conference is Just 1 week away Ophthalmic Drugs
News Ambrosia's sweet $100m round, and other biofinancings Our latest crop of biofinancings has a nine-figure round for Ambrosia, with Pinnacle Medicines, Immutrin, and Gilgamesh Pharma also raising new funds.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
